501 related articles for article (PubMed ID: 14685677)
21. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Wasmuth HE; Zaldivar MM; Berres ML; Werth A; Scholten D; Hillebrandt S; Tacke F; Schmitz P; Dahl E; Wiederholt T; Hellerbrand C; Berg T; Weiskirchen R; Trautwein C; Lammert F
J Hepatol; 2008 Feb; 48(2):208-15. PubMed ID: 18078680
[TBL] [Abstract][Full Text] [Related]
22. Molecular bases of hepatic fibrogenesis - genetic and therapeutical implications in chronic viral C hepatitis.
Rogoveanu I; Săndulescu DL; Gheonea DI; Ciurea T; Comănescu V
Rom J Morphol Embryol; 2008; 49(1):21-5. PubMed ID: 18273498
[TBL] [Abstract][Full Text] [Related]
23. Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
Nalpas B; Lavialle-Meziani R; Plancoulaine S; Jouanguy E; Nalpas A; Munteanu M; Charlotte F; Ranque B; Patin E; Heath S; Fontaine H; Vallet-Pichard A; Pontoire D; Bourlière M; Casanova JL; Lathrop M; Bréchot C; Poynard T; Matsuda F; Pol S; Abel L
Gut; 2010 Aug; 59(8):1120-6. PubMed ID: 20587546
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease.
Osterreicher CH; Halangk J; Berg T; Patsenker E; Homann N; Hellerbrand C; Seitz HK; Eurich D; Stickel F
Cytokine; 2008 Apr; 42(1):18-23. PubMed ID: 18337117
[TBL] [Abstract][Full Text] [Related]
25. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C and liver fibrosis.
Schuppan D; Krebs A; Bauer M; Hahn EG
Cell Death Differ; 2003 Jan; 10 Suppl 1():S59-67. PubMed ID: 12655347
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C -- identifying patients with progressive liver injury.
Feld JJ; Liang TJ
Hepatology; 2006 Feb; 43(2 Suppl 1):S194-206. PubMed ID: 16447261
[TBL] [Abstract][Full Text] [Related]
28. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection.
Papatheodoridis GV; Paraskevis D
Liver Int; 2008 Jul; 28(6):764-6. PubMed ID: 18647140
[No Abstract] [Full Text] [Related]
29. The role of genetic polymorphisms in alcoholic liver disease.
Stickel F; Osterreicher CH
Alcohol Alcohol; 2006; 41(3):209-24. PubMed ID: 16492723
[TBL] [Abstract][Full Text] [Related]
30. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population.
Roy N; Mukhopadhyay I; Das K; Pandit P; Majumder PP; Santra A; Datta S; Banerjee S; Chowdhury A
Gene; 2012 Nov; 509(1):178-88. PubMed ID: 22902304
[TBL] [Abstract][Full Text] [Related]
32. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
Gressner AM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
34. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection.
Strnad P; Lienau TC; Tao GZ; Lazzeroni LC; Stickel F; Schuppan D; Omary MB
Hepatology; 2006 Jun; 43(6):1354-63. PubMed ID: 16729313
[TBL] [Abstract][Full Text] [Related]
35. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
36. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
Schott E; Witt H; Pascu M; van Boemmel F; Weich V; Bergk A; Halangk J; Müller T; Puhl G; Wiedenmann B; Berg T
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):947-51. PubMed ID: 18049163
[TBL] [Abstract][Full Text] [Related]
37. Liver fibrogenesis and genetic factors.
Boursier J; Louvet A
Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S3-9. PubMed ID: 21742298
[TBL] [Abstract][Full Text] [Related]
38. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
39. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease.
Von Hahn T; Halangk J; Witt H; Neumann K; Müller T; Puhl G; Neuhaus P; Nickel R; Beuers U; Wiedenmann B; Berg T
Scand J Gastroenterol; 2008; 43(5):584-92. PubMed ID: 18415752
[TBL] [Abstract][Full Text] [Related]
40. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease.
Krawczyk M; Grünhage F; Zimmer V; Lammert F
J Hepatol; 2011 Aug; 55(2):299-306. PubMed ID: 21168459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
